Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - digoxin 0.25mg;  ;  ;  ;  ; digoxin 0.25mg - tablet - 0.25 mg - active: digoxin 0.25mg         excipient: lactose monohydrate magnesium stearate maize starch pregelatinised maize starch purified water rice starch active: digoxin 0.25mg excipient: lactose monohydrate magnesium stearate maize starch purified water rice starch starch, oxidised - cardiac failure:- lanoxin is indicated in the management of chronic cardiac failure where the dominant problem is systolic dysfunction. its therapeutic benefit is greatest in those patients with ventricular dilatation. lanoxin is specifically indicated where cardiac failure is accompanied by atrial fibrillation. supraventricular arrhythmias:- lanoxin is indicated in the management of certain supraventricular arrhythmias, particularly atrial flutter and fibrillation, where a major beneficial effect is reduction of the ventricular rate.

Uusi-Seelanti - englanti - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - digoxin 0.0625mg;  ;  ;  ;  ; digoxin 0.0625mg - tablet - 0.0625 mg - active: digoxin 0.0625mg         excipient: indigo carmine lactose monohydrate magnesium stearate maize starch povidone pregelatinised maize starch purified water rice starch active: digoxin 0.0625mg excipient: indigo carmine lactose monohydrate magnesium stearate maize starch povidone purified water rice starch starch, oxidised - cardiac failure:- lanoxin is indicated in the management of chronic cardiac failure where the dominant problem is systolic dysfunction. its therapeutic benefit is greatest in those patients with ventricular dilatation. lanoxin is specifically indicated where cardiac failure is accompanied by atrial fibrillation. supraventricular arrhythmias:- lanoxin is indicated in the management of certain supraventricular arrhythmias, particularly atrial flutter and fibrillation, where a major beneficial effect is reduction of the ventricular rate.

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

abbott laboratories ireland ltd - verapamil hydrochloride - solution for inj/inf - 2.5 mg/ml

Kanada - englanti - Health Canada

teva canada limited - verapamil hydrochloride - tablet - 80mg - verapamil hydrochloride 80mg - miscellaneous calcium-channel blocking agents

Kanada - englanti - Health Canada

teva canada limited - verapamil hydrochloride - tablet - 120mg - verapamil hydrochloride 120mg - miscellaneous calcium-channel blocking agents

Kanada - englanti - Health Canada

apotex inc - verapamil hydrochloride - tablet - 80mg - verapamil hydrochloride 80mg - miscellaneous calcium-channel blocking agents

Kanada - englanti - Health Canada

gilead sciences, llc - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet - 600mg; 200mg; 300mg - efavirenz 600mg; emtricitabine 200mg; tenofovir disoproxil fumarate 300mg - nonnucleoside reverse transcriptase inhibitors

Kanada - englanti - Health Canada

mylan pharmaceuticals ulc - efavirenz - tablet - 600mg - efavirenz 600mg - nonnucleoside reverse transcriptase inhibitors

Kanada - englanti - Health Canada

teva canada limited - efavirenz - tablet - 600mg - efavirenz 600mg - nonnucleoside reverse transcriptase inhibitors

Kanada - englanti - Health Canada

teva canada limited - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet - 600mg; 200mg; 300mg - efavirenz 600mg; emtricitabine 200mg; tenofovir disoproxil fumarate 300mg - nonnucleoside reverse transcriptase inhibitors